1. Home
  2. QUAD vs INBX Comparison

QUAD vs INBX Comparison

Compare QUAD & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QUAD
  • INBX
  • Stock Information
  • Founded
  • QUAD 1971
  • INBX 2010
  • Country
  • QUAD United States
  • INBX United States
  • Employees
  • QUAD N/A
  • INBX N/A
  • Industry
  • QUAD Publishing
  • INBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • QUAD Consumer Discretionary
  • INBX Health Care
  • Exchange
  • QUAD Nasdaq
  • INBX Nasdaq
  • Market Cap
  • QUAD 304.4M
  • INBX 345.8M
  • IPO Year
  • QUAD 2010
  • INBX 2020
  • Fundamental
  • Price
  • QUAD $6.53
  • INBX $25.00
  • Analyst Decision
  • QUAD Strong Buy
  • INBX Hold
  • Analyst Count
  • QUAD 2
  • INBX 2
  • Target Price
  • QUAD $9.30
  • INBX N/A
  • AVG Volume (30 Days)
  • QUAD 384.8K
  • INBX 107.2K
  • Earning Date
  • QUAD 07-29-2025
  • INBX 08-13-2025
  • Dividend Yield
  • QUAD 4.88%
  • INBX N/A
  • EPS Growth
  • QUAD N/A
  • INBX N/A
  • EPS
  • QUAD N/A
  • INBX N/A
  • Revenue
  • QUAD $2,584,500,000.00
  • INBX $1,400,000.00
  • Revenue This Year
  • QUAD N/A
  • INBX N/A
  • Revenue Next Year
  • QUAD N/A
  • INBX N/A
  • P/E Ratio
  • QUAD N/A
  • INBX N/A
  • Revenue Growth
  • QUAD N/A
  • INBX N/A
  • 52 Week Low
  • QUAD $4.13
  • INBX $10.81
  • 52 Week High
  • QUAD $9.13
  • INBX $25.61
  • Technical
  • Relative Strength Index (RSI)
  • QUAD 59.76
  • INBX 65.23
  • Support Level
  • QUAD $6.00
  • INBX $22.40
  • Resistance Level
  • QUAD $6.64
  • INBX $24.48
  • Average True Range (ATR)
  • QUAD 0.35
  • INBX 1.39
  • MACD
  • QUAD -0.00
  • INBX 0.08
  • Stochastic Oscillator
  • QUAD 69.07
  • INBX 87.94

About QUAD Quad Graphics Inc

Quad/Graphics Inc provides print and marketing services to help customers market their products, services, and contents. The company operates in the commercial segment of the printing industry. It operates through three divisions. The United States print and related services segment consists of the company's American operations. Besides the complete set of print and marketing solutions, this segment also manufactures ink. The international segment includes the company's printing business in Europe and Latin America and others countries. The corporate segment is engaged in the general and administrative activities as well as associated costs. The company almost generates all its revenue from the American domestic market..

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: